Insider Trading: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

69.34USD
27 Jul 2015
Change (% chg)

-- (--)
Prev Close
$69.34
Open
--
Day's High
--
Day's Low
--
Volume
2,000
Avg. Vol
9,784,212
52-wk High
$71.60
52-wk Low
$51.37

Search Stocks
Saleki-Gerhardt Azita Options Exercised: 2,618
Trade Date: Thursday, 8 Aug 2013 Price: 44.78
Title: Officer Shares Held: 66,005
Type Traded: Direct Net Change in Shares This Filing: 4,965

Institutional Holders

% Shares Owned: 72.54%
# of Holders: 1,952
Total Shares Held: 1,155,552,871
3 Mo. Net Change: -742,973
# New Positions: 28
# Closed Positions: 12
# Increased Positions: 193
# Reduced Positions: 160
# Net Buyers: 33

Officers & Directors

Name Age Since Current Position

Richard Gonzalez

61 2013 Chairman of the Board, Chief Executive Officer

William Chase

47 2013 Executive Vice President, Chief Financial Officer

Michael Severino

49 2014 Executive Vice President - Research & Development, Chief Scientific Officer

Laura Schumacher

51 2013 Executive Vice President - Business Development, External Affairs, General Counsel

Carlos Alban

52 2013 Executive Vice President - Commercial Operations

Timothy Richmond

48 2013 Senior Vice President - Human Resources

Azita Saleki-Gerhardt

51 2013 Senior Vice President - Operations

Thomas Hurwich

54 2013 Vice President, Controller

Roy Roberts

69 2013 Lead Independent Director

Robert Alpern

64 2013 Independent Director

Roxanne Austin

54 2013 Independent Director

William Burnside

63 2013 Independent Director

Edward Liddy

69 2013 Independent Director

Edward Rapp

57 2013 Independent Director

Glenn Tilton

66 2013 Lead Independent Director

Frederick Waddell

61 2013 Independent Director
Search Stocks